Global FPR2 Agonists and Antagonists Market Growth (Status and Outlook) 2026-2032
The global FPR2 Agonists and Antagonists market size is predicted to grow from US$ 124 million in 2025 to US$ 359 million in 2032; it is expected to grow at a CAGR of 17.0% from 2026 to 2032.
The FPR2 agonist and antagonist industry has a gross profit margin of 50%-70%.
FPR2 agonists: Molecules that bind to N-formyl peptide receptor 2 (FPR2/ALX) and activate the receptor conformation and downstream signal transduction (which can manifest as complete agonism, partial agonism, or 'biased agonism'). A common characteristic of the FPR2 system is that the ligand can induce different signal biases and biological effects (e.g., pro-inflammatory or pro-inflammatory resolution/repair), therefore, research and development often further subdivides according to 'bias.'
FPR2 antagonists are peptides that bind to FPR2 and block receptor activation induced by agonists (typically manifested as inhibition of Ca?? mobilization, chemotaxis, and other readouts). They are used in tool research or potential therapeutic strategies to 'inhibit certain pathological responses mediated by FPR2.' Some commonly used tool antagonist peptides (e.g., WRW4) are frequently used to validate the specificity of FPR2-related effects.
From a 'raw material' perspective, FPR2 agonists/antagonists most commonly fall into two categories in research and development and supply: peptides and small molecules/lipids. Peptides (many tool agonist and antagonist peptides) are typically synthesized using solid-phase peptide synthesis (SPPS): the main raw materials are amino acid monomers, resin carriers, coupling/deprotection reagents, and large amounts of organic solvents, and they are highly dependent on HPLC purification and mass spectrometry analysis for release. Therefore, the cost structure often shows a high proportion of 'purification and detection,' with longer sequences, more hydrophobic sequences, or a greater likelihood of byproduct formation increasing the unit cost. Upgrading from research-grade to GMP-grade significantly increases costs due to additional documentation, validation, and more stringent testing.
For FPR2 agonist routes involving lipid mediators/lipoxygen-like molecules (or their mimics), the raw materials often come from chiral/unsaturated fragments, protecting groups, and solvents required for multi-step organic synthesis. This makes the cost more easily amplified by factors such as chemical instability, isomer control, low-temperature and light-protected storage and transportation, and complex purification. This is why many R&D efforts shift towards more stable mimics/small molecule agonists with better physicochemical properties to improve manufacturability and cost control.
Overall conclusion: Under the same purity and traceability requirements, short peptides have relatively more predictable costs but are expensive to purify and detect; lipids/complex small molecules are more affected by synthetic difficulty and stability/storage and transportation, resulting in greater fluctuations in unit cost.
United States market for FPR2 Agonists and Antagonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for FPR2 Agonists and Antagonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for FPR2 Agonists and Antagonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key FPR2 Agonists and Antagonists players cover Bio-Techne, Abcam, Enzo Life Sciences, MedChemExpress, Anaspec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “FPR2 Agonists and Antagonists Industry Forecast” looks at past sales and reviews total world FPR2 Agonists and Antagonists sales in 2025, providing a comprehensive analysis by region and market sector of projected FPR2 Agonists and Antagonists sales for 2026 through 2032. With FPR2 Agonists and Antagonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FPR2 Agonists and Antagonists industry.
This Insight Report provides a comprehensive analysis of the global FPR2 Agonists and Antagonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on FPR2 Agonists and Antagonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global FPR2 Agonists and Antagonists market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FPR2 Agonists and Antagonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FPR2 Agonists and Antagonists.
This report presents a comprehensive overview, market shares, and growth opportunities of FPR2 Agonists and Antagonists market by product type, application, key players and key regions and countries.
Segmentation by Type:
The FPR2 agonist and antagonist industry has a gross profit margin of 50%-70%.
FPR2 agonists: Molecules that bind to N-formyl peptide receptor 2 (FPR2/ALX) and activate the receptor conformation and downstream signal transduction (which can manifest as complete agonism, partial agonism, or 'biased agonism'). A common characteristic of the FPR2 system is that the ligand can induce different signal biases and biological effects (e.g., pro-inflammatory or pro-inflammatory resolution/repair), therefore, research and development often further subdivides according to 'bias.'
FPR2 antagonists are peptides that bind to FPR2 and block receptor activation induced by agonists (typically manifested as inhibition of Ca?? mobilization, chemotaxis, and other readouts). They are used in tool research or potential therapeutic strategies to 'inhibit certain pathological responses mediated by FPR2.' Some commonly used tool antagonist peptides (e.g., WRW4) are frequently used to validate the specificity of FPR2-related effects.
From a 'raw material' perspective, FPR2 agonists/antagonists most commonly fall into two categories in research and development and supply: peptides and small molecules/lipids. Peptides (many tool agonist and antagonist peptides) are typically synthesized using solid-phase peptide synthesis (SPPS): the main raw materials are amino acid monomers, resin carriers, coupling/deprotection reagents, and large amounts of organic solvents, and they are highly dependent on HPLC purification and mass spectrometry analysis for release. Therefore, the cost structure often shows a high proportion of 'purification and detection,' with longer sequences, more hydrophobic sequences, or a greater likelihood of byproduct formation increasing the unit cost. Upgrading from research-grade to GMP-grade significantly increases costs due to additional documentation, validation, and more stringent testing.
For FPR2 agonist routes involving lipid mediators/lipoxygen-like molecules (or their mimics), the raw materials often come from chiral/unsaturated fragments, protecting groups, and solvents required for multi-step organic synthesis. This makes the cost more easily amplified by factors such as chemical instability, isomer control, low-temperature and light-protected storage and transportation, and complex purification. This is why many R&D efforts shift towards more stable mimics/small molecule agonists with better physicochemical properties to improve manufacturability and cost control.
Overall conclusion: Under the same purity and traceability requirements, short peptides have relatively more predictable costs but are expensive to purify and detect; lipids/complex small molecules are more affected by synthetic difficulty and stability/storage and transportation, resulting in greater fluctuations in unit cost.
United States market for FPR2 Agonists and Antagonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for FPR2 Agonists and Antagonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for FPR2 Agonists and Antagonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key FPR2 Agonists and Antagonists players cover Bio-Techne, Abcam, Enzo Life Sciences, MedChemExpress, Anaspec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “FPR2 Agonists and Antagonists Industry Forecast” looks at past sales and reviews total world FPR2 Agonists and Antagonists sales in 2025, providing a comprehensive analysis by region and market sector of projected FPR2 Agonists and Antagonists sales for 2026 through 2032. With FPR2 Agonists and Antagonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FPR2 Agonists and Antagonists industry.
This Insight Report provides a comprehensive analysis of the global FPR2 Agonists and Antagonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on FPR2 Agonists and Antagonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global FPR2 Agonists and Antagonists market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FPR2 Agonists and Antagonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FPR2 Agonists and Antagonists.
This report presents a comprehensive overview, market shares, and growth opportunities of FPR2 Agonists and Antagonists market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Agonists
- Antagonists
- Lipid Mediators
- Peptides
- Proteins
- Small Molecule Synthetic Compounds
- Endogenous
- Exogenous
- Pharmaceutical Company
- Universities and Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bio-Techne
- Abcam
- Enzo Life Sciences
- MedChemExpress
- Anaspec
- Merck
- Discoverx
- BioGems
- GenScript Company
- Alomone Labs
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global FPR2 Agonists and Antagonists Market Size (2021-2032)
2.1.2 FPR2 Agonists and Antagonists Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for FPR2 Agonists and Antagonists by Country/Region (2021, 2025 & 2032)
2.2 FPR2 Agonists and Antagonists Segment by Type
2.2.1 Agonists
2.2.2 Antagonists
2.2.3 FPR2 Agonists and Antagonists Market Size by Type
2.2.3.1 FPR2 Agonists and Antagonists Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
2.3 FPR2 Agonists and Antagonists Segment by Molecular Type
2.3.1 Lipid Mediators
2.3.2 Peptides
2.3.3 Proteins
2.3.4 Small Molecule Synthetic Compounds
2.3.5 FPR2 Agonists and Antagonists Market Size by Molecular Type
2.3.5.1 FPR2 Agonists and Antagonists Market Size CAGR by Molecular Type (2021 VS 2025 VS 2032)
2.3.5.2 Global FPR2 Agonists and Antagonists Market Size Market Share by Molecular Type (2021-2026)
2.4 FPR2 Agonists and Antagonists Segment by Source
2.4.1 Endogenous
2.4.2 Exogenous
2.4.3 FPR2 Agonists and Antagonists Market Size by Source
2.4.3.1 FPR2 Agonists and Antagonists Market Size CAGR by Source (2021 VS 2025 VS 2032)
2.4.3.2 Global FPR2 Agonists and Antagonists Market Size Market Share by Source (2021-2026)
2.5 FPR2 Agonists and Antagonists Segment by Application
2.5.1 Pharmaceutical Company
2.5.2 Universities and Research Institutes
2.5.3 Others
2.5.4 FPR2 Agonists and Antagonists Market Size by Application
2.5.4.1 FPR2 Agonists and Antagonists Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
3 FPR2 AGONISTS AND ANTAGONISTS MARKET SIZE BY PLAYER
3.1 FPR2 Agonists and Antagonists Market Size Market Share by Player
3.1.1 Global FPR2 Agonists and Antagonists Revenue by Player (2021-2026)
3.1.2 Global FPR2 Agonists and Antagonists Revenue Market Share by Player (2021-2026)
3.2 Global FPR2 Agonists and Antagonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 FPR2 AGONISTS AND ANTAGONISTS BY REGION
4.1 FPR2 Agonists and Antagonists Market Size by Region (2021-2026)
4.2 Global FPR2 Agonists and Antagonists Annual Revenue by Country/Region (2021-2026)
4.3 Americas FPR2 Agonists and Antagonists Market Size Growth (2021-2026)
4.4 APAC FPR2 Agonists and Antagonists Market Size Growth (2021-2026)
4.5 Europe FPR2 Agonists and Antagonists Market Size Growth (2021-2026)
4.6 Middle East & Africa FPR2 Agonists and Antagonists Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas FPR2 Agonists and Antagonists Market Size by Country (2021-2026)
5.2 Americas FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
5.3 Americas FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC FPR2 Agonists and Antagonists Market Size by Region (2021-2026)
6.2 APAC FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
6.3 APAC FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe FPR2 Agonists and Antagonists Market Size by Country (2021-2026)
7.2 Europe FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
7.3 Europe FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa FPR2 Agonists and Antagonists by Region (2021-2026)
8.2 Middle East & Africa FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
8.3 Middle East & Africa FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL FPR2 AGONISTS AND ANTAGONISTS MARKET FORECAST
10.1 Global FPR2 Agonists and Antagonists Forecast by Region (2027-2032)
10.1.1 Global FPR2 Agonists and Antagonists Forecast by Region (2027-2032)
10.1.2 Americas FPR2 Agonists and Antagonists Forecast
10.1.3 APAC FPR2 Agonists and Antagonists Forecast
10.1.4 Europe FPR2 Agonists and Antagonists Forecast
10.1.5 Middle East & Africa FPR2 Agonists and Antagonists Forecast
10.2 Americas FPR2 Agonists and Antagonists Forecast by Country (2027-2032)
10.2.1 United States Market FPR2 Agonists and Antagonists Forecast
10.2.2 Canada Market FPR2 Agonists and Antagonists Forecast
10.2.3 Mexico Market FPR2 Agonists and Antagonists Forecast
10.2.4 Brazil Market FPR2 Agonists and Antagonists Forecast
10.3 APAC FPR2 Agonists and Antagonists Forecast by Region (2027-2032)
10.3.1 China FPR2 Agonists and Antagonists Market Forecast
10.3.2 Japan Market FPR2 Agonists and Antagonists Forecast
10.3.3 Korea Market FPR2 Agonists and Antagonists Forecast
10.3.4 Southeast Asia Market FPR2 Agonists and Antagonists Forecast
10.3.5 India Market FPR2 Agonists and Antagonists Forecast
10.3.6 Australia Market FPR2 Agonists and Antagonists Forecast
10.4 Europe FPR2 Agonists and Antagonists Forecast by Country (2027-2032)
10.4.1 Germany Market FPR2 Agonists and Antagonists Forecast
10.4.2 France Market FPR2 Agonists and Antagonists Forecast
10.4.3 UK Market FPR2 Agonists and Antagonists Forecast
10.4.4 Italy Market FPR2 Agonists and Antagonists Forecast
10.4.5 Russia Market FPR2 Agonists and Antagonists Forecast
10.5 Middle East & Africa FPR2 Agonists and Antagonists Forecast by Region (2027-2032)
10.5.1 Egypt Market FPR2 Agonists and Antagonists Forecast
10.5.2 South Africa Market FPR2 Agonists and Antagonists Forecast
10.5.3 Israel Market FPR2 Agonists and Antagonists Forecast
10.5.4 Turkey Market FPR2 Agonists and Antagonists Forecast
10.6 Global FPR2 Agonists and Antagonists Forecast by Type (2027-2032)
10.7 Global FPR2 Agonists and Antagonists Forecast by Application (2027-2032)
10.7.1 GCC Countries Market FPR2 Agonists and Antagonists Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bio-Techne
11.1.1 Bio-Techne Company Information
11.1.2 Bio-Techne FPR2 Agonists and Antagonists Product Offered
11.1.3 Bio-Techne FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bio-Techne Main Business Overview
11.1.5 Bio-Techne Latest Developments
11.2 Abcam
11.2.1 Abcam Company Information
11.2.2 Abcam FPR2 Agonists and Antagonists Product Offered
11.2.3 Abcam FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Abcam Main Business Overview
11.2.5 Abcam Latest Developments
11.3 Enzo Life Sciences
11.3.1 Enzo Life Sciences Company Information
11.3.2 Enzo Life Sciences FPR2 Agonists and Antagonists Product Offered
11.3.3 Enzo Life Sciences FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Enzo Life Sciences Main Business Overview
11.3.5 Enzo Life Sciences Latest Developments
11.4 MedChemExpress
11.4.1 MedChemExpress Company Information
11.4.2 MedChemExpress FPR2 Agonists and Antagonists Product Offered
11.4.3 MedChemExpress FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MedChemExpress Main Business Overview
11.4.5 MedChemExpress Latest Developments
11.5 Anaspec
11.5.1 Anaspec Company Information
11.5.2 Anaspec FPR2 Agonists and Antagonists Product Offered
11.5.3 Anaspec FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Anaspec Main Business Overview
11.5.5 Anaspec Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck FPR2 Agonists and Antagonists Product Offered
11.6.3 Merck FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Discoverx
11.7.1 Discoverx Company Information
11.7.2 Discoverx FPR2 Agonists and Antagonists Product Offered
11.7.3 Discoverx FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Discoverx Main Business Overview
11.7.5 Discoverx Latest Developments
11.8 BioGems
11.8.1 BioGems Company Information
11.8.2 BioGems FPR2 Agonists and Antagonists Product Offered
11.8.3 BioGems FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BioGems Main Business Overview
11.8.5 BioGems Latest Developments
11.9 GenScript Company
11.9.1 GenScript Company Company Information
11.9.2 GenScript Company FPR2 Agonists and Antagonists Product Offered
11.9.3 GenScript Company FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 GenScript Company Main Business Overview
11.9.5 GenScript Company Latest Developments
11.10 Alomone Labs
11.10.1 Alomone Labs Company Information
11.10.2 Alomone Labs FPR2 Agonists and Antagonists Product Offered
11.10.3 Alomone Labs FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Alomone Labs Main Business Overview
11.10.5 Alomone Labs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global FPR2 Agonists and Antagonists Market Size (2021-2032)
2.1.2 FPR2 Agonists and Antagonists Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for FPR2 Agonists and Antagonists by Country/Region (2021, 2025 & 2032)
2.2 FPR2 Agonists and Antagonists Segment by Type
2.2.1 Agonists
2.2.2 Antagonists
2.2.3 FPR2 Agonists and Antagonists Market Size by Type
2.2.3.1 FPR2 Agonists and Antagonists Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
2.3 FPR2 Agonists and Antagonists Segment by Molecular Type
2.3.1 Lipid Mediators
2.3.2 Peptides
2.3.3 Proteins
2.3.4 Small Molecule Synthetic Compounds
2.3.5 FPR2 Agonists and Antagonists Market Size by Molecular Type
2.3.5.1 FPR2 Agonists and Antagonists Market Size CAGR by Molecular Type (2021 VS 2025 VS 2032)
2.3.5.2 Global FPR2 Agonists and Antagonists Market Size Market Share by Molecular Type (2021-2026)
2.4 FPR2 Agonists and Antagonists Segment by Source
2.4.1 Endogenous
2.4.2 Exogenous
2.4.3 FPR2 Agonists and Antagonists Market Size by Source
2.4.3.1 FPR2 Agonists and Antagonists Market Size CAGR by Source (2021 VS 2025 VS 2032)
2.4.3.2 Global FPR2 Agonists and Antagonists Market Size Market Share by Source (2021-2026)
2.5 FPR2 Agonists and Antagonists Segment by Application
2.5.1 Pharmaceutical Company
2.5.2 Universities and Research Institutes
2.5.3 Others
2.5.4 FPR2 Agonists and Antagonists Market Size by Application
2.5.4.1 FPR2 Agonists and Antagonists Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
3 FPR2 AGONISTS AND ANTAGONISTS MARKET SIZE BY PLAYER
3.1 FPR2 Agonists and Antagonists Market Size Market Share by Player
3.1.1 Global FPR2 Agonists and Antagonists Revenue by Player (2021-2026)
3.1.2 Global FPR2 Agonists and Antagonists Revenue Market Share by Player (2021-2026)
3.2 Global FPR2 Agonists and Antagonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 FPR2 AGONISTS AND ANTAGONISTS BY REGION
4.1 FPR2 Agonists and Antagonists Market Size by Region (2021-2026)
4.2 Global FPR2 Agonists and Antagonists Annual Revenue by Country/Region (2021-2026)
4.3 Americas FPR2 Agonists and Antagonists Market Size Growth (2021-2026)
4.4 APAC FPR2 Agonists and Antagonists Market Size Growth (2021-2026)
4.5 Europe FPR2 Agonists and Antagonists Market Size Growth (2021-2026)
4.6 Middle East & Africa FPR2 Agonists and Antagonists Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas FPR2 Agonists and Antagonists Market Size by Country (2021-2026)
5.2 Americas FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
5.3 Americas FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC FPR2 Agonists and Antagonists Market Size by Region (2021-2026)
6.2 APAC FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
6.3 APAC FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe FPR2 Agonists and Antagonists Market Size by Country (2021-2026)
7.2 Europe FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
7.3 Europe FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa FPR2 Agonists and Antagonists by Region (2021-2026)
8.2 Middle East & Africa FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
8.3 Middle East & Africa FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL FPR2 AGONISTS AND ANTAGONISTS MARKET FORECAST
10.1 Global FPR2 Agonists and Antagonists Forecast by Region (2027-2032)
10.1.1 Global FPR2 Agonists and Antagonists Forecast by Region (2027-2032)
10.1.2 Americas FPR2 Agonists and Antagonists Forecast
10.1.3 APAC FPR2 Agonists and Antagonists Forecast
10.1.4 Europe FPR2 Agonists and Antagonists Forecast
10.1.5 Middle East & Africa FPR2 Agonists and Antagonists Forecast
10.2 Americas FPR2 Agonists and Antagonists Forecast by Country (2027-2032)
10.2.1 United States Market FPR2 Agonists and Antagonists Forecast
10.2.2 Canada Market FPR2 Agonists and Antagonists Forecast
10.2.3 Mexico Market FPR2 Agonists and Antagonists Forecast
10.2.4 Brazil Market FPR2 Agonists and Antagonists Forecast
10.3 APAC FPR2 Agonists and Antagonists Forecast by Region (2027-2032)
10.3.1 China FPR2 Agonists and Antagonists Market Forecast
10.3.2 Japan Market FPR2 Agonists and Antagonists Forecast
10.3.3 Korea Market FPR2 Agonists and Antagonists Forecast
10.3.4 Southeast Asia Market FPR2 Agonists and Antagonists Forecast
10.3.5 India Market FPR2 Agonists and Antagonists Forecast
10.3.6 Australia Market FPR2 Agonists and Antagonists Forecast
10.4 Europe FPR2 Agonists and Antagonists Forecast by Country (2027-2032)
10.4.1 Germany Market FPR2 Agonists and Antagonists Forecast
10.4.2 France Market FPR2 Agonists and Antagonists Forecast
10.4.3 UK Market FPR2 Agonists and Antagonists Forecast
10.4.4 Italy Market FPR2 Agonists and Antagonists Forecast
10.4.5 Russia Market FPR2 Agonists and Antagonists Forecast
10.5 Middle East & Africa FPR2 Agonists and Antagonists Forecast by Region (2027-2032)
10.5.1 Egypt Market FPR2 Agonists and Antagonists Forecast
10.5.2 South Africa Market FPR2 Agonists and Antagonists Forecast
10.5.3 Israel Market FPR2 Agonists and Antagonists Forecast
10.5.4 Turkey Market FPR2 Agonists and Antagonists Forecast
10.6 Global FPR2 Agonists and Antagonists Forecast by Type (2027-2032)
10.7 Global FPR2 Agonists and Antagonists Forecast by Application (2027-2032)
10.7.1 GCC Countries Market FPR2 Agonists and Antagonists Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bio-Techne
11.1.1 Bio-Techne Company Information
11.1.2 Bio-Techne FPR2 Agonists and Antagonists Product Offered
11.1.3 Bio-Techne FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bio-Techne Main Business Overview
11.1.5 Bio-Techne Latest Developments
11.2 Abcam
11.2.1 Abcam Company Information
11.2.2 Abcam FPR2 Agonists and Antagonists Product Offered
11.2.3 Abcam FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Abcam Main Business Overview
11.2.5 Abcam Latest Developments
11.3 Enzo Life Sciences
11.3.1 Enzo Life Sciences Company Information
11.3.2 Enzo Life Sciences FPR2 Agonists and Antagonists Product Offered
11.3.3 Enzo Life Sciences FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Enzo Life Sciences Main Business Overview
11.3.5 Enzo Life Sciences Latest Developments
11.4 MedChemExpress
11.4.1 MedChemExpress Company Information
11.4.2 MedChemExpress FPR2 Agonists and Antagonists Product Offered
11.4.3 MedChemExpress FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MedChemExpress Main Business Overview
11.4.5 MedChemExpress Latest Developments
11.5 Anaspec
11.5.1 Anaspec Company Information
11.5.2 Anaspec FPR2 Agonists and Antagonists Product Offered
11.5.3 Anaspec FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Anaspec Main Business Overview
11.5.5 Anaspec Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck FPR2 Agonists and Antagonists Product Offered
11.6.3 Merck FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Discoverx
11.7.1 Discoverx Company Information
11.7.2 Discoverx FPR2 Agonists and Antagonists Product Offered
11.7.3 Discoverx FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Discoverx Main Business Overview
11.7.5 Discoverx Latest Developments
11.8 BioGems
11.8.1 BioGems Company Information
11.8.2 BioGems FPR2 Agonists and Antagonists Product Offered
11.8.3 BioGems FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BioGems Main Business Overview
11.8.5 BioGems Latest Developments
11.9 GenScript Company
11.9.1 GenScript Company Company Information
11.9.2 GenScript Company FPR2 Agonists and Antagonists Product Offered
11.9.3 GenScript Company FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 GenScript Company Main Business Overview
11.9.5 GenScript Company Latest Developments
11.10 Alomone Labs
11.10.1 Alomone Labs Company Information
11.10.2 Alomone Labs FPR2 Agonists and Antagonists Product Offered
11.10.3 Alomone Labs FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Alomone Labs Main Business Overview
11.10.5 Alomone Labs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. FPR2 Agonists and Antagonists Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. FPR2 Agonists and Antagonists Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Agonists
Table 4. Major Players of Antagonists
Table 5. FPR2 Agonists and Antagonists Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 7. Global FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Lipid Mediators
Table 9. Major Players of Peptides
Table 10. Major Players of Proteins
Table 11. Major Players of Small Molecule Synthetic Compounds
Table 12. FPR2 Agonists and Antagonists Market Size CAGR by Molecular Type (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global FPR2 Agonists and Antagonists Market Size by Molecular Type (2021-2026) & ($ millions)
Table 14. Global FPR2 Agonists and Antagonists Market Size Market Share by Molecular Type (2021-2026)
Table 15. Major Players of Endogenous
Table 16. Major Players of Exogenous
Table 17. FPR2 Agonists and Antagonists Market Size CAGR by Source (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global FPR2 Agonists and Antagonists Market Size by Source (2021-2026) & ($ millions)
Table 19. Global FPR2 Agonists and Antagonists Market Size Market Share by Source (2021-2026)
Table 20. FPR2 Agonists and Antagonists Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 22. Global FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Table 23. Global FPR2 Agonists and Antagonists Revenue by Player (2021-2026) & ($ millions)
Table 24. Global FPR2 Agonists and Antagonists Revenue Market Share by Player (2021-2026)
Table 25. FPR2 Agonists and Antagonists Key Players Head office and Products Offered
Table 26. FPR2 Agonists and Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global FPR2 Agonists and Antagonists Market Size by Region (2021-2026) & ($ millions)
Table 30. Global FPR2 Agonists and Antagonists Market Size Market Share by Region (2021-2026)
Table 31. Global FPR2 Agonists and Antagonists Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global FPR2 Agonists and Antagonists Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas FPR2 Agonists and Antagonists Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas FPR2 Agonists and Antagonists Market Size Market Share by Country (2021-2026)
Table 35. Americas FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Table 37. Americas FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Table 39. APAC FPR2 Agonists and Antagonists Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC FPR2 Agonists and Antagonists Market Size Market Share by Region (2021-2026)
Table 41. APAC FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe FPR2 Agonists and Antagonists Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe FPR2 Agonists and Antagonists Market Size Market Share by Country (2021-2026)
Table 45. Europe FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa FPR2 Agonists and Antagonists Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of FPR2 Agonists and Antagonists
Table 51. Key Market Challenges & Risks of FPR2 Agonists and Antagonists
Table 52. Key Industry Trends of FPR2 Agonists and Antagonists
Table 53. Global FPR2 Agonists and Antagonists Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global FPR2 Agonists and Antagonists Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global FPR2 Agonists and Antagonists Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global FPR2 Agonists and Antagonists Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Bio-Techne Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 58. Bio-Techne FPR2 Agonists and Antagonists Product Offered
Table 59. Bio-Techne FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bio-Techne Main Business
Table 61. Bio-Techne Latest Developments
Table 62. Abcam Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 63. Abcam FPR2 Agonists and Antagonists Product Offered
Table 64. Abcam FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Abcam Main Business
Table 66. Abcam Latest Developments
Table 67. Enzo Life Sciences Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 68. Enzo Life Sciences FPR2 Agonists and Antagonists Product Offered
Table 69. Enzo Life Sciences FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Enzo Life Sciences Main Business
Table 71. Enzo Life Sciences Latest Developments
Table 72. MedChemExpress Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 73. MedChemExpress FPR2 Agonists and Antagonists Product Offered
Table 74. MedChemExpress FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. MedChemExpress Main Business
Table 76. MedChemExpress Latest Developments
Table 77. Anaspec Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 78. Anaspec FPR2 Agonists and Antagonists Product Offered
Table 79. Anaspec FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Anaspec Main Business
Table 81. Anaspec Latest Developments
Table 82. Merck Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 83. Merck FPR2 Agonists and Antagonists Product Offered
Table 84. Merck FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Discoverx Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 88. Discoverx FPR2 Agonists and Antagonists Product Offered
Table 89. Discoverx FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Discoverx Main Business
Table 91. Discoverx Latest Developments
Table 92. BioGems Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 93. BioGems FPR2 Agonists and Antagonists Product Offered
Table 94. BioGems FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. BioGems Main Business
Table 96. BioGems Latest Developments
Table 97. GenScript Company Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 98. GenScript Company FPR2 Agonists and Antagonists Product Offered
Table 99. GenScript Company FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. GenScript Company Main Business
Table 101. GenScript Company Latest Developments
Table 102. Alomone Labs Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 103. Alomone Labs FPR2 Agonists and Antagonists Product Offered
Table 104. Alomone Labs FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Alomone Labs Main Business
Table 106. Alomone Labs Latest Developments
Table 1. FPR2 Agonists and Antagonists Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. FPR2 Agonists and Antagonists Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Agonists
Table 4. Major Players of Antagonists
Table 5. FPR2 Agonists and Antagonists Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 7. Global FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Lipid Mediators
Table 9. Major Players of Peptides
Table 10. Major Players of Proteins
Table 11. Major Players of Small Molecule Synthetic Compounds
Table 12. FPR2 Agonists and Antagonists Market Size CAGR by Molecular Type (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global FPR2 Agonists and Antagonists Market Size by Molecular Type (2021-2026) & ($ millions)
Table 14. Global FPR2 Agonists and Antagonists Market Size Market Share by Molecular Type (2021-2026)
Table 15. Major Players of Endogenous
Table 16. Major Players of Exogenous
Table 17. FPR2 Agonists and Antagonists Market Size CAGR by Source (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global FPR2 Agonists and Antagonists Market Size by Source (2021-2026) & ($ millions)
Table 19. Global FPR2 Agonists and Antagonists Market Size Market Share by Source (2021-2026)
Table 20. FPR2 Agonists and Antagonists Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 22. Global FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Table 23. Global FPR2 Agonists and Antagonists Revenue by Player (2021-2026) & ($ millions)
Table 24. Global FPR2 Agonists and Antagonists Revenue Market Share by Player (2021-2026)
Table 25. FPR2 Agonists and Antagonists Key Players Head office and Products Offered
Table 26. FPR2 Agonists and Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global FPR2 Agonists and Antagonists Market Size by Region (2021-2026) & ($ millions)
Table 30. Global FPR2 Agonists and Antagonists Market Size Market Share by Region (2021-2026)
Table 31. Global FPR2 Agonists and Antagonists Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global FPR2 Agonists and Antagonists Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas FPR2 Agonists and Antagonists Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas FPR2 Agonists and Antagonists Market Size Market Share by Country (2021-2026)
Table 35. Americas FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Table 37. Americas FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Table 39. APAC FPR2 Agonists and Antagonists Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC FPR2 Agonists and Antagonists Market Size Market Share by Region (2021-2026)
Table 41. APAC FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe FPR2 Agonists and Antagonists Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe FPR2 Agonists and Antagonists Market Size Market Share by Country (2021-2026)
Table 45. Europe FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa FPR2 Agonists and Antagonists Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa FPR2 Agonists and Antagonists Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa FPR2 Agonists and Antagonists Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of FPR2 Agonists and Antagonists
Table 51. Key Market Challenges & Risks of FPR2 Agonists and Antagonists
Table 52. Key Industry Trends of FPR2 Agonists and Antagonists
Table 53. Global FPR2 Agonists and Antagonists Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global FPR2 Agonists and Antagonists Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global FPR2 Agonists and Antagonists Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global FPR2 Agonists and Antagonists Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Bio-Techne Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 58. Bio-Techne FPR2 Agonists and Antagonists Product Offered
Table 59. Bio-Techne FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bio-Techne Main Business
Table 61. Bio-Techne Latest Developments
Table 62. Abcam Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 63. Abcam FPR2 Agonists and Antagonists Product Offered
Table 64. Abcam FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Abcam Main Business
Table 66. Abcam Latest Developments
Table 67. Enzo Life Sciences Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 68. Enzo Life Sciences FPR2 Agonists and Antagonists Product Offered
Table 69. Enzo Life Sciences FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Enzo Life Sciences Main Business
Table 71. Enzo Life Sciences Latest Developments
Table 72. MedChemExpress Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 73. MedChemExpress FPR2 Agonists and Antagonists Product Offered
Table 74. MedChemExpress FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. MedChemExpress Main Business
Table 76. MedChemExpress Latest Developments
Table 77. Anaspec Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 78. Anaspec FPR2 Agonists and Antagonists Product Offered
Table 79. Anaspec FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Anaspec Main Business
Table 81. Anaspec Latest Developments
Table 82. Merck Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 83. Merck FPR2 Agonists and Antagonists Product Offered
Table 84. Merck FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Discoverx Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 88. Discoverx FPR2 Agonists and Antagonists Product Offered
Table 89. Discoverx FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Discoverx Main Business
Table 91. Discoverx Latest Developments
Table 92. BioGems Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 93. BioGems FPR2 Agonists and Antagonists Product Offered
Table 94. BioGems FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. BioGems Main Business
Table 96. BioGems Latest Developments
Table 97. GenScript Company Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 98. GenScript Company FPR2 Agonists and Antagonists Product Offered
Table 99. GenScript Company FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. GenScript Company Main Business
Table 101. GenScript Company Latest Developments
Table 102. Alomone Labs Details, Company Type, FPR2 Agonists and Antagonists Area Served and Its Competitors
Table 103. Alomone Labs FPR2 Agonists and Antagonists Product Offered
Table 104. Alomone Labs FPR2 Agonists and Antagonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Alomone Labs Main Business
Table 106. Alomone Labs Latest Developments
LIST OF FIGURES
Figure 1. FPR2 Agonists and Antagonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global FPR2 Agonists and Antagonists Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. FPR2 Agonists and Antagonists Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. FPR2 Agonists and Antagonists Sales Market Share by Country/Region (2025)
Figure 8. FPR2 Agonists and Antagonists Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global FPR2 Agonists and Antagonists Market Size Market Share by Type in 2025
Figure 10. Global FPR2 Agonists and Antagonists Market Size Market Share by Molecular Type in 2025
Figure 11. Global FPR2 Agonists and Antagonists Market Size Market Share by Source in 2025
Figure 12. FPR2 Agonists and Antagonists in Pharmaceutical Company
Figure 13. Global FPR2 Agonists and Antagonists Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 14. FPR2 Agonists and Antagonists in Universities and Research Institutes
Figure 15. Global FPR2 Agonists and Antagonists Market: Universities and Research Institutes (2021-2026) & ($ millions)
Figure 16. FPR2 Agonists and Antagonists in Others
Figure 17. Global FPR2 Agonists and Antagonists Market: Others (2021-2026) & ($ millions)
Figure 18. Global FPR2 Agonists and Antagonists Market Size Market Share by Application in 2025
Figure 19. Global FPR2 Agonists and Antagonists Revenue Market Share by Player in 2025
Figure 20. Global FPR2 Agonists and Antagonists Market Size Market Share by Region (2021-2026)
Figure 21. Americas FPR2 Agonists and Antagonists Market Size 2021-2026 ($ millions)
Figure 22. APAC FPR2 Agonists and Antagonists Market Size 2021-2026 ($ millions)
Figure 23. Europe FPR2 Agonists and Antagonists Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa FPR2 Agonists and Antagonists Market Size 2021-2026 ($ millions)
Figure 25. Americas FPR2 Agonists and Antagonists Value Market Share by Country in 2025
Figure 26. United States FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC FPR2 Agonists and Antagonists Market Size Market Share by Region in 2025
Figure 31. APAC FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Figure 32. APAC FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Figure 33. China FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 37. India FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe FPR2 Agonists and Antagonists Market Size Market Share by Country in 2025
Figure 40. Europe FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Figure 41. Europe FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Figure 42. Germany FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 43. France FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 44. UK FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa FPR2 Agonists and Antagonists Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Figure 50. Egypt FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 56. APAC FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 57. Europe FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 59. United States FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 60. Canada FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 61. Mexico FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 62. Brazil FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 63. China FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 64. Japan FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 65. Korea FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 67. India FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 68. Australia FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 69. Germany FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 70. France FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 71. UK FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 72. Italy FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 73. Russia FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 74. Egypt FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 75. South Africa FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 76. Israel FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 77. Turkey FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 78. Global FPR2 Agonists and Antagonists Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global FPR2 Agonists and Antagonists Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 1. FPR2 Agonists and Antagonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global FPR2 Agonists and Antagonists Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. FPR2 Agonists and Antagonists Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. FPR2 Agonists and Antagonists Sales Market Share by Country/Region (2025)
Figure 8. FPR2 Agonists and Antagonists Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global FPR2 Agonists and Antagonists Market Size Market Share by Type in 2025
Figure 10. Global FPR2 Agonists and Antagonists Market Size Market Share by Molecular Type in 2025
Figure 11. Global FPR2 Agonists and Antagonists Market Size Market Share by Source in 2025
Figure 12. FPR2 Agonists and Antagonists in Pharmaceutical Company
Figure 13. Global FPR2 Agonists and Antagonists Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 14. FPR2 Agonists and Antagonists in Universities and Research Institutes
Figure 15. Global FPR2 Agonists and Antagonists Market: Universities and Research Institutes (2021-2026) & ($ millions)
Figure 16. FPR2 Agonists and Antagonists in Others
Figure 17. Global FPR2 Agonists and Antagonists Market: Others (2021-2026) & ($ millions)
Figure 18. Global FPR2 Agonists and Antagonists Market Size Market Share by Application in 2025
Figure 19. Global FPR2 Agonists and Antagonists Revenue Market Share by Player in 2025
Figure 20. Global FPR2 Agonists and Antagonists Market Size Market Share by Region (2021-2026)
Figure 21. Americas FPR2 Agonists and Antagonists Market Size 2021-2026 ($ millions)
Figure 22. APAC FPR2 Agonists and Antagonists Market Size 2021-2026 ($ millions)
Figure 23. Europe FPR2 Agonists and Antagonists Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa FPR2 Agonists and Antagonists Market Size 2021-2026 ($ millions)
Figure 25. Americas FPR2 Agonists and Antagonists Value Market Share by Country in 2025
Figure 26. United States FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC FPR2 Agonists and Antagonists Market Size Market Share by Region in 2025
Figure 31. APAC FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Figure 32. APAC FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Figure 33. China FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 37. India FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe FPR2 Agonists and Antagonists Market Size Market Share by Country in 2025
Figure 40. Europe FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Figure 41. Europe FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Figure 42. Germany FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 43. France FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 44. UK FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa FPR2 Agonists and Antagonists Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa FPR2 Agonists and Antagonists Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2026)
Figure 50. Egypt FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries FPR2 Agonists and Antagonists Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 56. APAC FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 57. Europe FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 59. United States FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 60. Canada FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 61. Mexico FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 62. Brazil FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 63. China FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 64. Japan FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 65. Korea FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 67. India FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 68. Australia FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 69. Germany FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 70. France FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 71. UK FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 72. Italy FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 73. Russia FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 74. Egypt FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 75. South Africa FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 76. Israel FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 77. Turkey FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
Figure 78. Global FPR2 Agonists and Antagonists Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global FPR2 Agonists and Antagonists Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries FPR2 Agonists and Antagonists Market Size 2027-2032 ($ millions)
